Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
Burckhart T, Thiel M, Nishikawa H, Wüest T, Müller D, Zippelius A, Ritter G, Old L, Shiku H, Renner C. Burckhart T, et al. Among authors: zippelius a. J Immunother. 2010 Nov-Dec;33(9):925-34. doi: 10.1097/CJI.0b013e3181f3cc87. J Immunother. 2010. PMID: 20948444
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients.
Zippelius A, Gati A, Bartnick T, Walton S, Odermatt B, Jaeger E, Dummer R, Urosevic M, Filonenko V, Osanai K, Moch H, Chen YT, Old LJ, Knuth A, Jaeger D. Zippelius A, et al. Cancer Immunol Immunother. 2007 Feb;56(2):249-58. doi: 10.1007/s00262-006-0177-z. Epub 2006 May 23. Cancer Immunol Immunother. 2007. PMID: 16718472 Free PMC article.
[Identification of tumor antigens: strategies and perspectives].
Zippelius A, Knights A, Tinguely M, Jäger D, Renner C, Knuth A. Zippelius A, et al. Dtsch Med Wochenschr. 2006 Aug 18;131(33):1809-12. doi: 10.1055/s-2006-949159. Dtsch Med Wochenschr. 2006. PMID: 16902905 Review. German. No abstract available.
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Tinguely M, Jenni B, Knights A, Lopes B, Korol D, Rousson V, Curioni Fontecedro A, Cogliatti SB, Bittermann AG, Schmid U, Dommann-Scherrer C, Maurer R, Renner C, Probst-Hensch NM, Moch H, Knuth A, Zippelius A. Tinguely M, et al. Among authors: zippelius a. Cancer Sci. 2008 Apr;99(4):720-5. doi: 10.1111/j.1349-7006.2008.00738.x. Epub 2008 Feb 27. Cancer Sci. 2008. PMID: 18307538 Free PMC article.
Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients.
Speiser DE, Schwarz K, Baumgaertner P, Manolova V, Devevre E, Sterry W, Walden P, Zippelius A, Conzett KB, Senti G, Voelter V, Cerottini JP, Guggisberg D, Willers J, Geldhof C, Romero P, Kündig T, Knuth A, Dummer R, Trefzer U, Bachmann MF. Speiser DE, et al. Among authors: zippelius a. J Immunother. 2010 Oct;33(8):848-58. doi: 10.1097/CJI.0b013e3181f1d614. J Immunother. 2010. PMID: 20842051 Clinical Trial.
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
Kashyap AS, Thelemann T, Klar R, Kallert SM, Festag J, Buchi M, Hinterwimmer L, Schell M, Michel S, Jaschinski F, Zippelius A. Kashyap AS, et al. Among authors: zippelius a. J Immunother Cancer. 2019 Mar 12;7(1):67. doi: 10.1186/s40425-019-0545-9. J Immunother Cancer. 2019. PMID: 30871609 Free PMC article.
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).
Liewen H, Markuly N, Läubli H, Liu Y, Matter MS, Liewen N, Renner C, Zippelius A, Stenner F. Liewen H, et al. Among authors: zippelius a. Target Oncol. 2019 Oct;14(5):577-590. doi: 10.1007/s11523-019-00667-z. Target Oncol. 2019. PMID: 31541350
244 results